"IRIDEX is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases, including the leading causes of irreversible blindness. The primary treatment of many eye diseases (such as macular degeneration, glaucoma, retinal detachments, and ocular tumors) is photocoagulation, the minimal heating of the ocular tissue to create a therapeutic response. The company's OcuLight System is an alternative to photocoagulator systems that use vacuum tubes. The system is sold worldwide, primarily to hospitals for use by ophthalmic specialists. Approximately half of the company's revenues come from international sales in 63 countries."
Looks like the OcuLight GL is selling well now and the supply problems are closed to being resolved. Though IRIX experienced growing pains in 1996, the new year promises to be much more positive and they have positioned themselves for growth.
Not only are they helping the world, but IRIX looks like a great buy right now. There are only 6mil shares outstanding and the market cap is under $50 million, SO WATCH OUT! With that small of a float, if this one gets hot, it could easily (yes, I said easily) be in the $20-$30 range by the end of the year.
Welcome to the IRIX thread. |
